Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China-Reference-Cited by-同舟云学术

Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Dai Peixi¹,Wang Qing²,Jia Mengmeng²,Leng Zhiwei²,Xie Shuyun³,Feng Luzhao²^ORCID,Yang Weizhong²

Affiliation:

1. Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China

2. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

3. Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China

Funder

Bill and Melinda Gates Foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2194190

Reference64 articles.

1. The expanded programme on immunization: the 1974 resolution by the world health assembly;World Health Assembly (27th: 1974);Assignment Child,1985

2. The National People’s Congress of the People’s Republic of China. Vaccine administration law of the People’s Republic of China. [accessed 2022 Apr 22]. http://www.npc.gov.cn/npc/c30834/201907/11447c85e05840b9b12c62b5b645fe9d.shtml. (in Chinese).

3. Japan Health Policy Now. Routine and voluntary immunization. [accessed 2022 May 25]. https://japanhpn.org/en/vaccinations-2/.

4. Two centuries of immunisation in the UK (part II)

5. GOV.UK. Historical vaccine development and introduction of vaccines in the UK. [accessed 2022 May 25]. https://www.gov.uk/government/publications/vaccination-timeline.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging artificial intelligence in vaccine development: A narrative review;Journal of Microbiological Methods;2024-09

2. Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019–2022;Frontiers in Public Health;2024-03-26

3. Analysis of data from two influenza surveillance hospitals in Zhejiang province, China, for the period 2018–2022;PLOS ONE;2024-02-28

4. Respiratory pathogenic microbial infections: a narrative review;International Journal of Medical Sciences;2024

5. Modeling the optimal seasonal monoclonal antibody administration strategy for respiratory syncytial virus (RSV) prevention based on age-season specific hospitalization rate of RSV in Suzhou, China, 2016–2022;Vaccine;2024-01